CTOs on the Move

Center For Growth and Healing

www.growthandhealing.com

 
Center For Growth and Healing is a Kenmore, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Hunstman Expandable Polymers Co.

Hunstman Expandable Polymers Co. is a High Point, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Northwestern Medical Center

Northwestern Medical Center, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Northwestern Medical Center, Inc. is based in Saint Albans, VT. You can find more information on Northwestern Medical Center, Inc. at www.nmcinc.org

Brooks Rand

Brooks Rand is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Skokie Park District

Explore the many facilities, parks and programs that the Skokie Park District has to offer.

ContraVir Pharmaceuticals, Inc

ContraVir is a biopharmaceutical company focused primarily on the development of drugs to treat herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus or VZV. Our lead candidate, FV-100, is an orally available nucleoside analogue prodrug of CF-1743 that we are developing for the treatment of shingles. Published preclinical studies demonstrate that FV-100 is significantly more potent against VZV than acyclovir, valacyclovir, and famciclovir, the FDA-approved drugs used for the treatment of shingles. Preclinical studies further demonstrate that FV-100 has a more rapid onset of antiviral activity, and may fully inhibit the replication of VZV more rapidly than these drugs at significantly lower concentration levels. In addition, pharmacokinetic data from completed phase 1 and 2 clinical trials suggest that FV-100 has the potential to demonstrate antiviral activity when dosed orally once-a-day at significantly lower levels than valacyclovir, acyclovir, and famciclovir.